HFA Premium Access

Is HFpEF a disease of women? From biological to epidemiological evidence

Event: Heart Failure 2021 Online Congress
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session type: Symposium
Date: 1 July 2021
Time: 08:55 - 09:40

Session

Become an HFA member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Sex-based differences in HFpEF: phenotyping and biological implications.

Speaker: Associate Professor M. Tokmakova (Plovdiv, BG)
Thumbnail

Sex-based differences in HFpEF: implications for the diagnostic algorithm.

Speaker: Doctor A. Rakisheva (Almaty, KZ)
Thumbnail

Sex-based differences in HFpEF: therapeutic implications.

Speaker: Doctor M. Senni (Bergamo, IT)
Thumbnail

Is HFpEF a disease of women? From biological to epidemiological evidence - discussion.

Thumbnail

3 speakers from this session

Associate Professor Mariya Tokmakova

University Multiprofile Hospital for Active Treatment Sv. Georgi Medical University Plovdiv, Plovdiv (Bulgaria)
3 presentations
0 follower

Doctor Amina Rakisheva

Scientific Research Institute of Cardiology and Internal Diseases, Almaty (Kazakhstan)
4 presentations
7 followers

Doctor Michele Senni

Papa Giovanni XXIII Hospital, Bergamo (Italy)
36 presentations
0 follower

Related content

ESC Premium Access

Artificial intelligence in cardiology

4 December 2021

ESC Premium Access

Use of combination therapies in hypertension management: how to fill the gap between current guidelines and current clinical practice?

3 December 2021

This platform is supported by

logo Novo Nordisk